Catalyst Pharmaceuticals' investment merits are bolstered by a favorable settlement announced on January 8. Read why I rate ...
JCPenney merges with Sparc Group to form Catalyst Brands, combining six brands and boasting $9 billion in revenue.
Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...
Stanford researchers have introduced a software tool that accelerates and enhances the analysis of single atom catalysts, ...
Seaport analyst Jeff Cantwell downgraded Mastercard Incorporated (NYSE:MA) to Neutral from Buy rating, with a price target of ...
J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers ...
SMCI's intrinsic value is calculated at $85, presenting a potential 160% upside from the current share price of $32.6.